BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belenchia AM, Gavini MP, Toedebusch RG, DeMarco VG, Pulakat L. Comparison of Cardiac miRNA Transcriptomes Induced by Diabetes and Rapamycin Treatment and Identification of a Rapamycin-Associated Cardiac MicroRNA Signature. Oxid Med Cell Longev. 2018;2018:8364608. [PMID: 30647817 DOI: 10.1155/2018/8364608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kambis TN, Tofilau HMN, Gawargi FI, Chandra S, Mishra PK. Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy. Curr Diab Rep 2021;21:52. [PMID: 34902085 DOI: 10.1007/s11892-021-01429-w] [Reference Citation Analysis]
2 Gavini MP, Mahmood A, Belenchia AM, Beauparlant P, Kumar SA, Ardhanari S, DeMarco VG, Pulakat L. Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4. Front Pharmacol 2021;12:693167. [PMID: 34220518 DOI: 10.3389/fphar.2021.693167] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Aroor AR, Mummidi S, Lopez-Alvarenga JC, Das N, Habibi J, Jia G, Lastra G, Chandrasekar B, DeMarco VG. Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness. Cardiovasc Diabetol 2021;20:80. [PMID: 33882908 DOI: 10.1186/s12933-021-01270-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yan LN, Zhang X, Xu F, Fan YY, Ge B, Guo H, Li ZL. Four-microRNA signature for detection of type 2 diabetes. World J Clin Cases 2020; 8(10): 1923-1931 [PMID: 32518782 DOI: 10.12998/wjcc.v8.i10.1923] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
5 Pulakat L, Chen HH. Pro-Senescence and Anti-Senescence Mechanisms of Cardiovascular Aging: Cardiac MicroRNA Regulation of Longevity Drug-Induced Autophagy. Front Pharmacol 2020;11:774. [PMID: 32528294 DOI: 10.3389/fphar.2020.00774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
6 Wang X, Wang Q, Li W, Zhang Q, Jiang Y, Guo D, Sun X, Lu W, Li C, Wang Y. TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity. J Exp Clin Cancer Res 2020;39:93. [PMID: 32448281 DOI: 10.1186/s13046-020-01595-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
7 Xu X, Kobayashi S, Timm D, Huang Y, Zhao F, Shou W, Liang Q. Enhanced mTOR complex 1 signaling attenuates diabetic cardiac injury in OVE26 mice. FASEB J 2019;33:12800-11. [PMID: 31469601 DOI: 10.1096/fj.201901206R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]